Back to Search
Start Over
Figure S2 from Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation–Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Investigator-assessed percent change at maximum reduction from baseline in tumor measurement per RANO criteria
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....006db3819fbf55943d79bcc53f8717b2